近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.Cines, Douglas B; Wasser, Jeffrey; Rodeghiero, Francesco; Chong, Beng H; Steurer, Michael; Provan, Drew; Lyons, Roger; Garcia-Chavez, Jaime; Carpenter, Nancy; Wang, Xuena; Eisen, Melissa Haematologica 2017 Apr;
Cost of Bleeding-related Episodes in Adult Patients With Primary Immune Thrombocytopenia: A Population-based Retrospective Cohort Study of Administrative Claims Data for Commercial Payers in the United States.Lin, Junji; Zhang, Xinke; Li, Xiaoyan; Chandler, David; Altomare, Ivy; Wasser, Jeffrey S; Cetin, Karynsa Clinical therapeutics 2017 Feb;
Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy.Adler, Adam J; Mittal, Payal; Ryan, Joseph M; Zhou, Beiyan; Wasser, Jeffrey S; Vella, Anthony T Immunotherapy 2017 Jan;9(1):71-82
Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?Ryan, Joseph M; Wasser, Jeffrey S; Adler, Adam J; Vella, Anthony T Expert opinion on biological therapy 2016 Feb;
Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claims database in the US.Altomare, Ivy; Cetin, Karynsa; Wetten, Sally; Wasser, Jeffrey S Clinical epidemiology 2016 Jan;8231-9
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines.Shimanovsky, Alexei; Patel, Devbala; Wasser, Jeffrey Mediterranean journal of hematology and infectious diseases 2016 Jan;8(1):e2016010
Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopenia.Michel, Marc; Wasser, Jeffrey; Godeau, Bertrand; Aledort, Louis; Cooper, Nichola; Tomiyama, Yoshiaki; Khellaf, Mehdi; Wang, Xuena Annals of hematology 2015 Dec;94(12):1973-80
Tumor-Unrelated CD4 T Cell Help Augments CD134 Plus CD137 Dual Costimulation Tumor Therapy.Mittal, Payal; St Rose, Marie-Clare; Wang, Xi; Ryan, Joseph M; Wasser, Jeffrey S; Vella, Anthony T; Adler, Adam J Journal of immunology (Baltimore, Md. : 1950) 2015 Nov;
Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim.Cines, Douglas B; Gernsheimer, Terry; Wasser, Jeffrey; Godeau, Bertrand; Provan, Drew; Lyons, Roger; Altomare, Ivy; Wang, Xuena; Lopez, Angela International journal of hematology 2015 Sep;102(3):259-70
Targeting HER2 in the treatment of non-small cell lung cancer.Mar, Nataliya; Vredenburgh, James J; Wasser, Jeffrey S Lung cancer (Amsterdam, Netherlands) 2015 Jan;87(3):220-5
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenias: safety and efficacyDavid J. Kuter, James Brussel, Adrian Newland, Ross I Baker, Roger M. Lyons, Jeffrey Wasser, Jean-Francois Viallard, Gail Macik, Mathias Rummel, Kun Nie and Susie Jun. British Journal of Haematology 2013 Jun;161(3):411-423
Bleeding and mortality outcomes in ITP clinical trials: a review of thrombopoietin mimetics data.Altomare, Ivy; Wasser, Jeffrey; Pullarkat, Vinod American journal of hematology 2012 Oct;87(10):984-7
Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531).Pullarkat, Vinod A; Gernsheimer, Terry B; Wasser, Jeffrey S; Newland, Adrian; Guthrie, Troy H; de Wolf, Joost Th M; Stewart, Ron; Berger, Dietmar American journal of hematology 2009 Aug;84(8):538-40
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind Randomized controlled trial.Kuter, D.J., Bussel, J.B., Lyons, R.M., Pullarkat, V., Gernsheimer, T.B., Senecal, F.M., Aledort, L.M., George, J.N., Kessler, C.M., Sanz, M.A., Liebman, H.A., Slovik, F.T., de Wolf, T.M., Bourgeois, E., Wasser, J.S., et. al. Lancet 2008 Jan;371395-403
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.Bussel, James B; Kuter, David J; George, James N; McMillan, Robert; Aledort, Louis M; Conklin, George T; Lichtin, Alan E; Lyons, Roger M; Nieva, Jorge; Wasser, Jeffrey S; Wiznitzer, Israel; Kelly, Reggie; Chen, Chien-Feng; Nichol, Janet L The New England journal of medicine 2006 Oct;355(16):1672-81
Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life.Hudis, Clifford A; Vogel, Charles L; Gralow, Julie R; Williams, Denise Clinical breast cancer 2005 Jun;6(2):132-42
Prospective Screening of 205 Patients With ITP, Including Diagnosis, Serological Markers, and the Relationship Between Platelet Counts, Endogenous Thrombopoietin, and Circulating Antithrombopoietin Antibodies. - Member of ITP Study GroupAledort, L.M., Hayward, C.P.M., et al for the ITP Study Group American Journal of Hematology 2004 Jan;76205-213
Safety and Effect on Platelet Count of Single-Dose Monoclonal Antibody to CD40 Ligand (Antova) in Patients with Chronic ITP.George, J.M., Raskob, G., et al Blood 1998 Jan;92(10):
Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. The American Society of Hematology ITP Practice Guideline Panel.Wasser, J. Ann Intern Med. 1997 Jan;15(126(4):):319:26
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.George, J N; Woolf, S H; Raskob, G E; Wasser, J S; Aledort, L M; Ballem, P J; Blanchette, V S; Bussel, J B; Cines, D B; Kelton, J G; Lichtin, A E; McMillan, R; Okerbloom, J A; Regan, D H; Warrier, I Blood 1996 Jul;88(1):3-40
Diagnosis and treatment of idiopathic thrombocytopenic purpura. American Society of Hematology ITP Practice Guideline Panel.Wasser, J. Am Fam Physician 1996 Jan;54(8):2437-47
Melphalan and prednisone plus total bone marrow irradiation as initial treatment for multiple myeloma.McIntyre, O R; Tefft, M; Propert, K; Wolf, D J; Coleman, M; Leone, L; Cooper, M R; Eaton, W; Zimmer, B International journal of radiation oncology, biology, physics 1988 Oct;15(4):1007-12
Whole bone marrow irradiation for the treatment of multiple myeloma.Coleman, M; Saletan, S; Wolf, D; Nisce, L; Wasser, J; McIntyre, O R; Tulloh, M Cancer 1982 Apr;49(7):1328-33
Whole Bone Marrow Irradiation for the Treatment of Multiple Myeloma.Coleman,M., Saletan, S., Wolf, D., Niesce, L., Wasser, J.S., McIntyre, O.R., Tulloh, M. Cancer 1982 Jan;49(7):1328-1333
京公网安备 11010802027423号